Institute for Integration of Medicine & Science: A Partnership to Improve Health

医学整合研究所

基本信息

  • 批准号:
    10704865
  • 负责人:
  • 金额:
    $ 563.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-25 至 2030-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary-Abstract South-Central Texas is home to San Antonio and Austin, both among the nation’s fastest growing cities. San Antonio, the gateway to South Texas, is the 7th largest city and the largest minority- majority Hispanic/Latino city in the US, whereas Austin is 11th largest. The region also includes many rural counties and several on the US-Mexico border. Given our demographics and rapid growth, our area foreshadows future challenges facing US healthcare, underscoring the national applicability of solutions devised by our hub. In 2006, UT Health Science Center San Antonio established the Institute for Integration of Medicine & Science (IIMS) as the academic home for translational research initiatives, training the translational science workforce, formalizing key strategic partnerships, and creating a community of scholars within a learning healthcare system. Building upon our optimized clinical and translational research infrastructure, IIMS now proposes a 4th cycle of CTSA support in response to PAR-21-293. Our hub seeks to be exceptional in solving clinical and translational science (CTS) roadblocks, translating discoveries into reduced disparities and improved healthcare outcomes across our multi-cultural population. We strive to make our vision a reality through robust strategies for supporting CTS across institutional partners and collaborating organizations, catalyzing successes for transdisciplinary research teams, and implementing programs that produce a creative, collaborative, and culturally diverse translational science workforce. We will achieve our goals through the strategic deployment of resources and expertise developed during 3 cycles of CTSA funding. Our proposal leverages optimized strengths across the spectrum of clinical and translational research to establish the capacity and infrastructure required for high-impact CTS programs. Thus, IIMS will pivot from the study of specific targets/diseases (i.e., clinical translational research) to the discovery of generalizable principles that apply to many targets/diseases (CTS), addressing rate-limiting steps and transforming translation from an empirical process into a predictive science. This guiding tenet is embedded within each Element and Module of this proposal, as well as across our pipeline of training and workforce development programs. We posit that synergies across hub partners will yield CTS innovations and contribute meaningfully to the National CTSA Consortium. Our over-arching Specific Aims are: 1. Catalyze the acceleration of CTS discovery and health disparities impact within a vibrant academic home synergistically integrated with our strategic partners and actively engaged with our diverse communities 2. Capitalize on our extraordinary Hispanic and military/veteran population base to diversify and enhance our interdisciplinary clinical and translational science workforce 3. Implement innovative strategies for evaluation and continuous improvement across all IIMS programs 4. Focus strategically on dissemination and implementation of evidence-based CTS advances with high potential for advancing health equity, both regionally and across the National CTSA Consortium
项目摘要-摘要 得克萨斯州中南部是圣安东尼奥和奥斯汀的所在地,这两个城市都是美国最大的城市之一。 增长最快的城市圣安东尼奥是南德克萨斯州的门户,是第七大城市,也是最大的少数民族城市- 奥斯汀是美国西班牙裔/拉丁裔人口占多数的城市,而奥斯汀是第11大城市。该地区还包括许多农村 县和几个在美国和墨西哥边境。鉴于我们的人口和快速增长,我们的地区预示着 美国医疗保健面临的未来挑战,强调了我们中心设计的解决方案的全国适用性。 2006年,UT健康科学中心圣安东尼奥成立了医学与医学整合研究所。 科学(IIMS)作为转化研究倡议的学术家园,培养转化科学 劳动力,正式确定关键的战略伙伴关系,并在学习中创建学者社区 医疗保健系统。基于我们优化的临床和转化研究基础设施,IIMS现在 根据PAR-21-293,建议第四轮CTSA支持。我们的中心寻求在解决 临床和转化科学(CTS)障碍,将发现转化为减少差异并改善 我们的多元文化人口的医疗保健结果。我们致力于通过强大的 支持跨机构合作伙伴和协作组织的CTS的战略, 为跨学科的研究团队,并实施计划,产生一个创造性的,协作的, 文化多样的翻译科学工作者。我们将通过以下战略部署来实现我们的目标: 在CTSA的3个供资周期中开发的资源和专业知识。我们的方案利用优化的优势 跨临床和转化研究的范围,以建立所需的能力和基础设施, 高影响力的CTS项目因此,IIMS将从特定目标/疾病的研究(即,临床 转化研究)到发现适用于许多靶点/疾病的可推广原则(CTS), 解决限速步骤,并将翻译从经验过程转变为预测科学。 这一指导原则嵌入在本提案的每个元素和模块中,并贯穿我们的管道 培训和劳动力发展计划。我们认为,跨中心合作伙伴的协同效应将产生CTS 创新并为国家CTSA联盟做出有意义的贡献。我们的具体目标是: 1.在一个充满活力的学术家庭中加速CTS的发现和健康差异的影响 与我们的战略合作伙伴协同整合,并积极参与我们的多元化社区 2.利用我们非凡的西班牙裔和军人/退伍军人人口基础, 我们的跨学科临床和转化科学团队 3.在所有IIMS项目中实施创新的评估和持续改进战略 4.战略重点是传播和实施以证据为基础的CTS进展, 在区域和全国CTSA联盟范围内推进卫生公平的潜力

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT A CLARK其他文献

ROBERT A CLARK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT A CLARK', 18)}}的其他基金

Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
  • 批准号:
    10487947
  • 财政年份:
    2022
  • 资助金额:
    $ 563.56万
  • 项目类别:
Development of Sustainable Reporting to the National COVID Cohort Collaborative (N3C)
为国家新冠肺炎队列协作组织 (N3C) 制定可持续报告
  • 批准号:
    10244205
  • 财政年份:
    2020
  • 资助金额:
    $ 563.56万
  • 项目类别:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
  • 批准号:
    10404497
  • 财政年份:
    2018
  • 资助金额:
    $ 563.56万
  • 项目类别:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
嗅觉障碍对帕金森病早期诊断的分析
  • 批准号:
    10408715
  • 财政年份:
    2016
  • 资助金额:
    $ 563.56万
  • 项目类别:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
嗅觉障碍对帕金森病早期诊断的分析
  • 批准号:
    10254880
  • 财政年份:
    2016
  • 资助金额:
    $ 563.56万
  • 项目类别:
Analysis of Olfactory Dysfunction for Early Diagnosis of Parkinson's Disease
嗅觉障碍对帕金森病早期诊断的分析
  • 批准号:
    9137152
  • 财政年份:
    2016
  • 资助金额:
    $ 563.56万
  • 项目类别:
Pilot and Exploratory Studies Core (PESC)
试点和探索性研究核心(PESC)
  • 批准号:
    10670129
  • 财政年份:
    2015
  • 资助金额:
    $ 563.56万
  • 项目类别:
Pilot and Exploratory Studies Core (PESC)
试点和探索性研究核心(PESC)
  • 批准号:
    10221555
  • 财政年份:
    2015
  • 资助金额:
    $ 563.56万
  • 项目类别:
Pilot and Exploratory Studies Core (PESC)
试点和探索性研究核心(PESC)
  • 批准号:
    10455766
  • 财政年份:
    2015
  • 资助金额:
    $ 563.56万
  • 项目类别:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
  • 批准号:
    8877665
  • 财政年份:
    2013
  • 资助金额:
    $ 563.56万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 563.56万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了